In France, Mirko Beljanski PhD, working at the Pasteur Institute in Paris, was the first to investigate the anticancer activity of Pao pereira as an extract that would be effective against cancer cells, but not harm healthy cells.
With the support of The Beljanski Foundation, several publications by renowned academic institutions have confirmed the efficacy and lack of toxicity of Pao pereira extract (as prepared by Dr. Beljanski and is currently provided by Natural Source International) on different lines of cancer cells and in synergy with chemotherapy. If you consider taking Pao pereira for your condition, please call us first. There are many products in the market and only a few of them contain high concentration of the alkaloid that fights cancer cells.
Pao Pereira Backed By Research
In 2013, University of Kansas published the results of a study in Oncology Reports magazine, in which Pao pereira suppressed up to 72% of Pancreatic cancer’s tumor growth. Researchers from Columbia University explored the efficacy of Pao pereira on resistant prostate cancer cells. Their findings were published in Journal of the Society for Integrative Oncology – showing suppressions of up to 80% of tumor growth.
An ovarian cancer study conducted at the University of Kansas Medical Center found that in vivo, Pao alone suppressed tumor growth by 79% and decreased volume of ascites by 55%. When Pao pereira was combined with chemotherapy, tumor inhibition reach 97% and ascites was completely eradicated.
Finally, Pao pereira is also active against cancer stem cells. This is particularly important because it means the extract will be useful for preventing cancer recurrence. In cell-based studies the Pao pereira extract significantly reduced the pancreatic cancer stem cell population.
To learn more about the plant check out Pao pereira Monograph
Several publications published on the anticancer effect of his Pao pereira extract, which he called PB-100 (Pao pereira Beljanski 100), are dedicated to the efficiency and selectivity of its action:
PB100: A Potent and Selective Inhibitor of Human BCNU Resistant Glioblastoma Cell Multiplication. Authors : M. BELJANSKI, S. CROCHET, M.S. BELJANSKI. Anticancer Research, vol.13, n°6A, Nov. Dec. 1993, pp. 2301-2308. Available online in French, summary in English
The selective anticancer agent PB-100 inhibits interleukin-6 induced enhancement of glioblastoma cell proliferation in vitro. Authors : M. BELJANSKI, S. CROCHET. International Journal of Oncology, 5:873-879, 1994. Available online in English. French version upon request.
Selective inhibitor (PB-100) of human glioblastoma cell multiplication. Authors : S. CROCHET, M. BELJANSKI. International Journal of Oncology, 5:873-879, 1994. Available in English. French version available on request.
The anticancer agent PB-100 concentrates in the nucleus and nucleoli of human glioblastoma cells but does not enter normal astrocytes. Authors : S. CROCHET, M. BELJANSKI. International Journal of Oncology 7:81-85, 1995. Available in English only
Mitogenic Effect of Several Interleukins, Neuromediators and Hormones on Human Glioblastoma Cells, and its Inhibition by the Selective Anticancer Agent PB-100. Authors : S. CROCHET, M. BELJANSKI. Deutsche Zeitschrift für Onkologie, 28, 1, 1996, pp. 14-22. Available in English only
The anticancer Agent PB-100, Selectively Active on Malignant Cells, Inhibits Multiplication of 16 Malignant Cell Lines, even Multidrug Resistant. Authors : M. BELJANSKI (posthumous). Genetics and Molecular Biology 2000, vol 23 nº1, pp. 29. Available in English only
Several publications published on the anticancer effect of his Rauwolfia Vomitoria extract (BG-8), also mention his Pao Pereira extract (PB-100) :
Agonist and/or antagonists effects of plant hormones and an anticancer alkaloid on plant DNA structure and activity. Authors : L. LE GOFF, M. BELJANSKI. IRCS Medical Science, 10, 1982, pp. 689-690. Available in English only
A New Approach to Cancer Therapy. Authors : M. BELJANSKI. Proceedings of the international seminar: Traditional Medicine: a Challenge of the 21st Century, 7-9 Nov. 1992, Calcutta (ed. in chief Biswapati Mukherjee). Available in English only
The selective anticancer agents PB-100 and BG-8 are active against human melanoma cells, but do not affect non malignant fibroblasts. Authors : S. CROCHET, M. BELJANSKI. International Journal of Oncology 8:1143-1148, 1996. Available in English only
Toxicology studies, clastogenecity studies and mutagenecity studies have confirmed the safety of the extract.
- Traditional Use of Pao Pereira
Pao pereira (Geissospermum vellosii, or Geissospermum leave velloso), also spelled Pau pereira, is a well-known tree, native to South America. This plant, which has been used in traditional medicine for centuries, is also very much a part of South American popular culture.
Use of this plant extract spans a period of over three centuries, and information about its traditional use in South America, North America and Europe has been featured in a number of important publications.
On December 7, 1848, Ezequiel Correa Dos Santos presented his thesis “Monographia do Geissospermum vellosii vulgo Pao pereira” at the Faculty of Medicine of Rio de Janeiro. This document has come to be regarded as the first official monograph on the benefits of Pao pereira. In the third part of the study (p.17 “Therapeutica”), Dos Santos presented twenty-one cases of therapeutic use of Pao pereira. Before outlining the details of each case history, Dr. Dos Santos summarized his study with the following statement: “The administration of the Pao pereira bark was beneficial in cases of induration of cellular tissues, chronic diarrhea, passive hemorrhage, asthenia, as well as erysipelas.”
The subject was revisited in 1879 by the journal Medical Times (Vol. X p. 276 – Philadelphia) which published a two-page article devoted to Pao pereira. After a description of the method of extracting the alkaloid pereirina, Dr. Torres Homem, Professor of Clinical Medicine at the Academy of Rio de Janeiro states, “There is not a doctor in Brazil who has not obtained good results from the use of this bark in the treatment of intermittent fevers.” He mentions in particular the case of a patient for whom quinine was ineffective but who was cured after daily baths and oral administration of the Pao pereira bark extract.
The article “Antimalarial remedies in French Guiana: A knowledge attitudes and practices study” published in the Journal of Ethnopharmacology [98 (2005) 351-360], details a study on 117 people from five different ethnic groups and backgrounds, taking the alcoholic extract of Geissospermum (Pao pereira) at the onset of fevers.
“For example it was quite a surprise to see that one of the most renowned antimalarial Amazonian species, Geissospermum spp., was so poorly employed as curative, but on the contrary, used much more in favor as preventive.” (p. 358.) According to a questionnaire submitted by the authors, the main reason for using this traditional medicine was to “stay healthy.” (p. 355)
In line with the decline in the number of cases of malaria, Geissospermum continues to be considered very useful, though for a different purpose.
A Brazilian journal on medicinal plants, “Revista Da Flora Medicinal, (No. 9, September 1942, Rio de Janeiro), offers a botanical illustration (p. 463) and description of the tree (p. 464-465). It says that the “precious bark” can be found on “one of the most common and well–known trees in Brazil” and “is available for all herbalists” and concludes that, “the inner bark of Pao pereira is considered as one of the best tonic and febrifuge of the Brazilian flora.”
In “Livro verde das plantas medicinais e industriais do Brasil” (1965), the therapeutic usage of the Pao pereira is described as follows: “It is an excellent tonic and powerful remedy against intermittent fevers.” It is also recommended for digestive problems, lack of appetite and constipation.
It is most likely that the Pao pereira extract made its way to Northern America and Europe around the time of the big universal exhibitions, at the end of the 19th century.
Pao pereira was exhibited at the Universal Exhibition in Philadelphia and was included in the brochure: The Empire of Brazil at the Universal Exhibition of 1876 in Philadelphia—Medicinal Plants (p. 61).
It is interesting to note that the distinction between Geissospermum vellosii, and a somewhat similar botanical called Aspidosperma, was already made in 1876. In 1895, The American Journal of Pharmacy recommended Pao pereira as an anti-fever tonic, especially to combat the periodic fevers. In 1907, The Merck Index indicates that the roots of Geissospermum vellosii have anti-peristaltic and anti-fever effects.
Europe also showed early interest for Pao pereira. In “Notes, Queries and Replies” (p. 443 of “The Medical Times” London) published in 1884, Richard G. Daunt comments: “the efficacy of pereirina is extraordinary, and I have often observed its success after the failure of quinine.”
The same year in France, Dr. Tibiriça indicates in “La revue des journaux” (l’Union Médicale p.429 – Paris), “The Pereirine (extract from the bark of Pao pereira, Geissospermum leaf) fulfills the indication in a more satisfactory way than the quinine. It doubles the therapeutic action at the same time as it prevents the bad effects when pushed to a higher dose.”
Belgium made Pao pereira an official “new remedy”: in 1887 in “le Journal de Médecine, de Chirurgie et de Phamacologie” (Bruxelles) published in “Nouveaux remèdes” the following note: “the alkaloid pereirine would be more effective than quinine against malarial fevers. The dose of 2 g of hydrochloride is to be taken four hours prior the access.”
In 1933, in Milan, Italy, Pao pereira is listed in the dictionary of drugs “Medicamenta, Guida Teorico-pratica per Sanitari” (Dizionario dei Medicamenti p. 2389) included in the description are instructions for the pharmaceutical preparation and dosage: Internal, Decoction (30 gr: 1000) 1-2 glasses a day. Pereirine Chloride 2gr.
European scientists soon became interested in analyzing this valuable product with the means of modern chemistry.
In Belgium in 1959, Puisieux published and article on the nature of some of the alkaloids from Geissospermum (Ann Pharm Fr 1959 Oct-Dec; 17:626-33).
In 1996, Dr. Marcowith, friend and collaborator of Dr. Beljanski passed away, leaving behind notes on the use of Pao pereira in modern medicine. These notes were published in French in the book “Cancer: l’Approche Beljanski” and then in English in the book “Cancer’s cause, Cancer Cure” by Morton Walker. Most recently, the notes have been published in “Winning The War On Cancer: The Epic Journey Towards A Natural Cure” by Sylvie Beljanski.
You can read his cancer treatment protocols here – this is not a medical advice but notes written by one physician to another.
- Milestone in Cancer Stem Cell Research
- Publication on the anti-cancer and anti-inflammatory activities of Pao pereira
- Publication on Pao pereira Extract against Pancreatic Cancer
- Clinical Trial on the synergistic effects of Rauwolfia vomitoria and Pao pereira on elevated PSA
- Publication on Pao Pereira Extract Against Prostate Cancer
- Publication on Pao Pereira Extract Against Ovarian Cancer